Damora Therapeutics (DMRA) Accumulated Depreciation & Amortization (2021 - 2025)
Damora Therapeutics posted quarterly Accumulated Depreciation & Amortization of $72000.0 for Q4 2025, up 44.0% year-on-year from $50000.0 in Q4 2024, and up 7.46% on a QoQ basis from $67000.0 in Q3 2025.
Damora Therapeutics (DMRA) has 5 years of Accumulated Depreciation & Amortization data on file, last reported at $72000.0 in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 44.0% year-over-year to $72000.0; the trailing twelve-month figure through Dec 2025 stood at $72000.0 (up 44.0% YoY), and the FY2025 full-year result was $72000.0, up 44.0% from the prior year.
- Accumulated Depreciation & Amortization for Q4 2025 stood at $72000.0, up from $67000.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $305000.0 in Q3 2023 and bottomed at $2000.0 in Q1 2021.
- The 5-year median for Accumulated Depreciation & Amortization is $43000.0 (2022), against an average of $57000.0.
- The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization surged 1300.0%; it then tumbled 85.25% in 2024.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $20000.0 in 2021, then jumped by 210.0% to $62000.0 in 2022, then plunged by 53.23% to $29000.0 in 2023, then jumped by 72.41% to $50000.0 in 2024, then surged by 44.0% to $72000.0 in 2025.
- The last three Accumulated Depreciation & Amortization figures came in at $72000.0 (Q4 2025), $67000.0 (Q3 2025), and $61000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 72,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Sep 30, 2025 | 67,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Mar 31, 2025 | 55,000.00 |
| Mar 31, 2025 | 55,000.00 |
| Dec 31, 2024 | 50,000.00 |
| Dec 31, 2024 | 50,000.00 |
| Sep 30, 2024 | 45,000.00 |
| Sep 30, 2024 | 45,000.00 |
| Jun 30, 2024 | 39,000.00 |
| Jun 30, 2024 | 39,000.00 |
| Mar 31, 2024 | 34,000.00 |
| Mar 31, 2024 | 34,000.00 |
| Dec 31, 2023 | 29,000.00 |
| Dec 31, 2023 | 29,000.00 |
| Sep 30, 2023 | 305,000.00 |
| Sep 30, 2023 | 305,000.00 |
| Jun 30, 2023 | 97,000.00 |
| Jun 30, 2023 | 97,000.00 |
| Mar 31, 2023 | 80,000.00 |
| Mar 31, 2023 | 80,000.00 |
| Dec 31, 2022 | 62,000.00 |
| Dec 31, 2022 | 62,000.00 |
| Sep 30, 2022 | 41,000.00 |
| Sep 30, 2022 | 41,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |